theophylline has been researched along with 4-(3,4-dibutoxybenzyl)-2-imidazolidinone in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Duffie, GP; Ellis, NK; Wepsic, HT; Young, MR | 1 |
Lowenstein, JM; Ravid, K | 1 |
2 other study(ies) available for theophylline and 4-(3,4-dibutoxybenzyl)-2-imidazolidinone
Article | Year |
---|---|
The effects of 16,16-dimethyl PGE2 and phosphodiesterase inhibitors on Con A blastogenic responses and NK cytotoxic activity of mouse spleen cells.
Topics: 16,16-Dimethylprostaglandin E2; Animals; Cells, Cultured; Concanavalin A; Cyclic AMP; Cytotoxicity, Immunologic; Dipyridamole; Imidazoles; Immunosuppression Therapy; Killer Cells, Natural; Lymphocyte Activation; Lymphocytes; Male; Mice; Mice, Inbred Strains; Phosphodiesterase Inhibitors; Prostaglandins E, Synthetic; Spleen; Theophylline | 1990 |
Changes in adenosine receptors during differentiation of 3T3-F442A cells to adipocytes.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Adipose Tissue; Animals; Cell Differentiation; Cell Line; Colforsin; Cyclic AMP; Imidazoles; Isoproterenol; Mice; Phenylisopropyladenosine; Receptors, Purinergic; Theophylline | 1988 |